BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chakraborty M, Fullerton AM, Semple K, Chea LS, Proctor WR, Bourdi M, Kleiner DE, Zeng X, Ryan PM, Dagur PK, Berkson JD, Reilly TP, Pohl LR. Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment. Hepatology 2015;62:546-57. [PMID: 25712247 DOI: 10.1002/hep.27764] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Maiuri AR, Wassink B, Turkus JD, Breier AB, Lansdell T, Kaur G, Hession SL, Ganey PE, Roth RA. Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study. J Pharmacol Exp Ther 2017;362:459-73. [PMID: 28687704 DOI: 10.1124/jpet.117.242354] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 McGill MR, Jaeschke H. Animal models of drug-induced liver injury. Biochim Biophys Acta Mol Basis Dis 2019;1865:1031-9. [PMID: 31007174 DOI: 10.1016/j.bbadis.2018.08.037] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
3 Iorga A, Dara L, Kaplowitz N. Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis. Int J Mol Sci. 2017;18. [PMID: 28486401 DOI: 10.3390/ijms18051018] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 27.0] [Reference Citation Analysis]
4 Stollings LM, Jia LJ, Tang P, Dou H, Lu B, Xu Y. Immune Modulation by Volatile Anesthetics. Anesthesiology. 2016;125:399-411. [PMID: 27286478 DOI: 10.1097/aln.0000000000001195] [Cited by in Crossref: 97] [Cited by in F6Publishing: 55] [Article Influence: 24.3] [Reference Citation Analysis]
5 Tu C, Gao Y, Song D, Niu M, Ma RR, Zhou MX, He X, Xiao XH, Wang JB. Screening for Susceptibility-Related Biomarkers of Diclofenac-Induced Liver Injury in Rats Using Metabolomics. Front Pharmacol 2021;12:693928. [PMID: 34630079 DOI: 10.3389/fphar.2021.693928] [Reference Citation Analysis]
6 Usui T, Naisbitt DJ. Human leukocyte antigen and idiosyncratic adverse drug reactions. Drug Metabolism and Pharmacokinetics 2017;32:21-30. [DOI: 10.1016/j.dmpk.2016.11.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
7 Mak A, Kato R, Weston K, Hayes A, Uetrecht J. Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI. Toxicol Sci 2018;161:412-20. [PMID: 29087505 DOI: 10.1093/toxsci/kfx219] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
8 Iorga A, Dara L. Cell death in drug-induced liver injury. Adv Pharmacol. 2019;85:31-74. [PMID: 31307591 DOI: 10.1016/bs.apha.2019.01.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
9 Akai S, Oda S, Yokoi T. Strain and interindividual differences in lamotrigine-induced liver injury in mice. J Appl Toxicol 2019;39:451-60. [PMID: 30325050 DOI: 10.1002/jat.3736] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kleiner DE. Drugs and Toxins. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 673-779. [DOI: 10.1016/b978-0-7020-6697-9.00012-1] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Song B, Aoki S, Liu C, Susukida T, Ito K. An animal model of abacavir-induced HLA-mediated liver injury. Toxicol Sci. 2018;162:713-723. [PMID: 29319822 DOI: 10.1093/toxsci/kfy001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
12 Kenna JG. Human biology-based drug safety evaluation: scientific rationale, current status and future challenges. Expert Opin Drug Metab Toxicol 2017;13:567-74. [PMID: 28150517 DOI: 10.1080/17425255.2017.1290082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Uetrecht J. Mechanisms of idiosyncratic drug-induced liver injury. Drug-induced Liver Injury. Elsevier; 2019. pp. 133-63. [DOI: 10.1016/bs.apha.2018.12.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
14 Cho T, Uetrecht J. How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction. Chem Res Toxicol 2017;30:295-314. [DOI: 10.1021/acs.chemrestox.6b00357] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 14.6] [Reference Citation Analysis]
15 Roth RA, Maiuri AR, Ganey PE. Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin? J Pharmacol Exp Ther 2017;360:461-70. [PMID: 28104833 DOI: 10.1124/jpet.116.237578] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
16 Mak A, Cho TE, Uetrecht J. The Effects of Immune Modulators on Amodiaquine-Induced Liver Injury. Chem Res Toxicol 2018;31:739-44. [PMID: 29938495 DOI: 10.1021/acs.chemrestox.8b00091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Jee A, Sernoskie SC, Uetrecht J. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. Int J Mol Sci 2021;22:2954. [PMID: 33799477 DOI: 10.3390/ijms22062954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Mak A, Johnston A, Uetrecht J. Effects of immunization and checkpoint inhibition on amodiaquine-induced liver injury. J Immunotoxicol 2017;14:89-94. [PMID: 28279082 DOI: 10.1080/1547691X.2017.1290716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Liu W, Zeng X, Liu Y, Liu J, Li C, Chen L, Chen H, Ouyang D. The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury. Front Pharmacol 2021;12:723940. [PMID: 34721020 DOI: 10.3389/fphar.2021.723940] [Reference Citation Analysis]
20 Raschi E, De Ponti F. Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors. Front Pharmacol 2019;10:1235. [PMID: 31708776 DOI: 10.3389/fphar.2019.01235] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
21 Thompson RA, Isin EM, Ogese MO, Mettetal JT, Williams DP. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments. Chem Res Toxicol 2016;29:505-33. [DOI: 10.1021/acs.chemrestox.5b00410] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 15.8] [Reference Citation Analysis]
22 Rao T, Liu YT, Zeng XC, Li CP, Ou-Yang DS. The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury. Acta Pharmacol Sin. 2021;42:27-35. [PMID: 32123300 DOI: 10.1038/s41401-020-0360-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Stephens C, Lucena MI, Andrade RJ. Host Risk Modifiers in Idiosyncratic Drug-Induced Liver Injury (DILI) and Its Interplay with Drug Properties. In: Chen M, Will Y, editors. Drug-Induced Liver Toxicity. New York: Springer; 2018. pp. 477-96. [DOI: 10.1007/978-1-4939-7677-5_23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Dara L, Liu Z, Kaplowitz N. Pathogenesis of Idiosyncratic Drug Induced Liver Injury. Liver Pathophysiology. Elsevier; 2017. pp. 87-100. [DOI: 10.1016/b978-0-12-804274-8.00005-9] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Woolbright BL, Jaeschke H. Xenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the Liver. Adv Pharmacol 2015;74:131-61. [PMID: 26233906 DOI: 10.1016/bs.apha.2015.04.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
26 Dara L, Liu ZX, Kaplowitz N. Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. Liver Int. 2016;36:158-165. [PMID: 26484420 DOI: 10.1111/liv.12988] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 11.2] [Reference Citation Analysis]
27 Dara L, Kaplowitz N. Drug‐Induced Liver Injury. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, Wolkoff AW, editors. The Liver. Wiley; 2020. pp. 701-13. [DOI: 10.1002/9781119436812.ch54] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
28 Uetrecht J, Kaplowitz N. Inhibition of immune tolerance unmasks drug-induced allergic hepatitis. Hepatology 2015;62:346-8. [PMID: 25833746 DOI: 10.1002/hep.27824] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
29 Weaver RJ, Betts C, Blomme EAG, Gerets HHJ, Gjervig Jensen K, Hewitt PG, Juhila S, Labbe G, Liguori MJ, Mesens N, Ogese MO, Persson M, Snoeys J, Stevens JL, Walker T, Park BK. Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.Expert Opin Drug Metab Toxicol. 2017;13:767-782. [PMID: 28604124 DOI: 10.1080/17425255.2017.1341489] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
30 Zhang L, Niu M, Wei AW, Tang JF, Tu C, Bai ZF, Zou ZS, Xiao XH, Liu YP, Wang JB. Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum. Arch Toxicol 2020;94:245-56. [PMID: 31630224 DOI: 10.1007/s00204-019-02595-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
31 Lundgren H, Martinsson K, Cederbrant K, Jirholt J, Mucs D, Madeyski-Bengtson K, Havarinasab S, Hultman P. HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity. PLoS One 2017;12:e0184744. [PMID: 28934241 DOI: 10.1371/journal.pone.0184744] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
32 Mak A, Uetrecht J. The Combination of Anti-CTLA-4 and PD1-/- Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury. Chem Res Toxicol 2015;28:2287-91. [PMID: 26529122 DOI: 10.1021/acs.chemrestox.5b00305] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 8.3] [Reference Citation Analysis]